Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Intellectual disability-dysmorphism-hypogonadism-diabetes mellitus syndrome is characterized by moderate intellectual deficit, craniofacial dysmorphism (including broad nose with coloboma of the alea nasi, deep-set eyes, prognathism), hypergonadotropic hypogonadism, eunuchoid habitus, type 1 diabetes mellitus, and epilepsy. It has been described in four patients (three brothers and their sister). This syndrome is probably transmitted as an autosomal recessive trait.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for intellectual disability-dysmorphism-hypogonadism-diabetes mellitus syndrome.
44 publications have been identified in PubMed for intellectual disability-dysmorphism-hypogonadism-diabetes mellitus syndrome. Research spans Case Report / Case Series (38%), Review / Meta-Analysis (20%), and Epidemiology / Natural History (18%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 15 | 38% |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 4:39 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries |
8 |
20% |
Disease patterns and progression | 7 | 18% |
Clinical study results | 4 | 10% |
Laboratory research | 4 | 10% |
New treatment approaches | 2 | 5% |
Sinke L (2026). [PMID: 41057690](https://pubmed.ncbi.nlm.nih.gov/41057690/). *Diabetologia*. [Review / Meta-Analysis]
Neto MI (2026). [PMID: 41631087](https://pubmed.ncbi.nlm.nih.gov/41631087/). *Cureus*. [Case Report / Case Series]
Musumeci G (2026). [PMID: 42120867](https://pubmed.ncbi.nlm.nih.gov/42120867/). *Clin Drug Investig*. [Basic Science / Preclinical]
Yadav S (2026). [PMID: 42033524](https://pubmed.ncbi.nlm.nih.gov/42033524/). *Mol Biol Rep*. [Review / Meta-Analysis]
Smedegaard S (2026). [PMID: 41203981](https://pubmed.ncbi.nlm.nih.gov/41203981/). *Diabetologia*. [Clinical Trial Publication]
Zhang K (2026). [PMID: 41591480](https://pubmed.ncbi.nlm.nih.gov/41591480/). *Acta Diabetol*. [Case Report / Case Series]
Abizaid A (2026). [PMID: 41520674](https://pubmed.ncbi.nlm.nih.gov/41520674/). *Lancet*. [Clinical Trial Publication]
Dvoryanchikov YV (2026). [PMID: 42205255](https://pubmed.ncbi.nlm.nih.gov/42205255/). *Front Endocrinol (Lausanne)*. [Case Report / Case Series]
Nadal-Martínez A (2026). [PMID: 41977154](https://pubmed.ncbi.nlm.nih.gov/41977154/). *Int J Mol Sci*. [Gene Therapy / Novel Therapeutics]
Sheikh MM (2026). [PMID: 41932959](https://pubmed.ncbi.nlm.nih.gov/41932959/). *Sci Rep*. [Epidemiology / Natural History]